Company Name: Moleculin Biotech, Inc.
Moleculin Biotech, Inc. is a preclinical and clinical stage pharmaceutical company. The company is engaged in the development of anticancer drug candidates. The company’s lead product candidate is designed to treat relapsed or refractory acute myeloid leukemia (AML).
Ticker Symbol: MBRX (NASDAQ)
Company Website: www.moleculin.com
Headquarters: Houston, Texas